Physician profile
Robert Jaggers
NPI 1639165608
$4,366.86
in general payments reported to CMS, 2019-2025
38 companies · $1,084 in 2025
The $1,084 reported for 2025 was more than what 89% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $449 · 2020: $222 · 2021: $540 · 2022: $908 · 2023: $661 · 2024: $503 · 2025: $1,084.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,178 · Education: $69.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,178.07 |
| Education | $69.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $638.66 | 2019-2025 | Synergy Ablation System, Atricure Cryoice Cryosphere Cryoablation System |
| Astrazeneca Pharmaceuticals Lp | $341.27 | 2019-2025 | Imfinzi |
| Abiomed | $322.45 | 2021-2025 | |
| Davol INC. | $304.62 | 2023-2024 | Progel Applicator Spray Tips, Arista Ah Flexitip |
| Medtronic, INC. | $281.16 | 2023-2025 | Corevalve Evolut R, Endurant Iis, Signia |
| Merck Sharp & Dohme LLC | $227.33 | 2019-2025 | Keytruda |
| Novartis Pharmaceuticals Corporation | $163.82 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $155.99 | 2021-2025 | Libtayo |
| Amgen INC. | $145.48 | 2019-2023 | Lumakras |
| Medtronic Vascular, INC. | $140.14 | 2019 | |
| Edwards Lifesciences Corporation | $127.70 | 2025 | Sapien 3 Ultra Resilia |
| Boehringer Ingelheim Pharmaceuticals, INC. | $123.35 | 2019-2024 | Gilotrif |
| Janssen Pharmaceuticals, INC | $117.35 | 2023-2024 | Xarelto |
| Takeda Pharmaceuticals U.S.A., INC. | $117.21 | 2021-2025 | Alunbrig, Fruzaqla |
| Intuitive Surgical, INC. | $100.90 | 2019 |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $98.90 | 2024-2025 | Enhertu |
| Kls-Martin L.P. | $95.33 | 2021 | |
| Emd Serono, INC. | $93.29 | 2020-2025 | Tepmetko |
| Livanova USA, INC. | $88.85 | 2022 | |
| Genentech USA, INC. | $86.97 | 2024-2025 | Tecentriq, Alecensa |
| G1 Therapeutics, INC. | $64.77 | 2022 | |
| Genzyme Corporation | $58.45 | 2021-2022 | |
| Jazz Pharmaceuticals INC. | $50.92 | 2021-2023 | Zepzelca |
| Janssen Biotech, INC. | $49.41 | 2024-2025 | Rybrevant |
| Becton, Dickinson and Company | $46.32 | 2022 | |
| Pharmacosmos Therapeutics INC. | $41.82 | 2024-2025 | Monoferric, Cosela |
| Blueprint Medicines Corporation | $38.95 | 2020-2021 | |
| Biom'Up France Sas | $35.90 | 2020 | |
| Lilly USA, LLC | $31.81 | 2021-2022 | |
| Nuvation Bio INC. | $27.63 | 2025 | Ibtrozi |
| Pacira Pharmaceuticals Incorporated | $26.22 | 2025 | Exparel |
| Ethicon US, LLC | $25.09 | 2025 | Evarrest |
| Ethicon INC. | $22.59 | 2020 | |
| Lsi Solutions INC | $21.41 | 2025 | Cor-Knot |
| Aveo Pharmaceuticals, INC. | $15.53 | 2021 | |
| Getinge USA Sales, LLC | $14.04 | 2023 | Flixene |
| Bayer Healthcare Pharmaceuticals INC. | $12.77 | 2019 | |
| Seagen INC. | $12.46 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Jaggers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.